Net income increased 94.5%
Net income changed +94.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +94.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +94.6% from the comparable as-filed period.
Operating margin changed +32306 basis points from the comparable as-filed period.
Cash & equivalents changed -25.8% from the comparable as-filed period.
Gross margin changed -183 basis points from the comparable as-filed period.
Revenue changed -3.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed +29.3% from the comparable as-filed period.
Gross profit changed -6.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.